History

Ypsomed Group

• Ypsomed focuses on growth and strengthens its business units
• Changes in the Board of Directors at Ypsomed: The founder and Chairman of the Board of Directors of the Ypsomed Group Dr. h.c. Willy Michel does not stand for re-election as Chairman and member of the Board of Directors at the Annual General Meeting held on 29 June 2022. 
• Ypsomed increases sales by 15.2% and triples its operating profit
• Ypsomed successfully completes capital increase
• Annual General Meeting of Ypsomed elects new Chairman
• Ypsomed leaves DiaExpert in new hands and focuses on own products and authorised the Board to increase the share capital.

Ypsomed Diabetes Care

• Ypsomed partners with CamDiab Ltd to drive on smartphone based adaptive automated insulin delivery (AID)
• Ypsomed, Abbott and CamDiab unveil new automated insulin delivery partnership for people with diabetes
• Ypsomed launches bolus delivery from the smartphone on the mylife YpsoPump via the mylife App

Ypsomed Delivery Systems

• Ypsomed partners with leading digital therapeutics innovator Sidekick Health to improve therapy outcomes
• Ypsomed introduces new autoinjector for volumes up to 5.5 ml

Ypsomed Group

• Alliance to Zero founded to achieve net zero emissions across the pharmaceutical supply chain.
• The AGM elected Ms Betül Susamis Unaran as a new member of the Board of Directors and authorised the Board to increase the share capital.

Ypsomed Diabetes Care

• Ypsomed expands the range of features of the mylife YpsoPump insulin pump system with the app-based integration of the Dexcom G6 Continuous Glucose Monitoring (CGM) System.

Ypsomed Delivery Systems

• Ypsomed introduces the world’s first autoinjector for prefilled syringes with integrated connectivity.

Ypsomed Group

• Ypsomed creates 102 new jobs during COVID-19 crisis.
• Ypsomed establishes Software Devlopement Centre in Barcelona.
• Gilbert Achermann is elected as a new member of the Board of Directors.

Ypsomed Diabetes Care

• Ypsomed and Dexcom enter into partnership to drive closed loop system.
• Ypsomed launches Explorer app - a virtual oportunity to try out and interact with the mylife YpsoPump.

Ypsomed Delivery Systems

• Yposmed announces the world's first zero carbon emission autoinjector.
• Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed.

Ypsomed Group

• In the USA, Ypsomed founds its subsidiary.
• In Schwerin, Germany, Ypsomed opens the world's most modern production site for medical products.
• In Burgdorf and Solothurn, Switzerland, Ypsomed expands its office capacities.

Ypsomed Diabetes Care

• The mylife YpsoPump insulin pump is launched in Canada, Croatia, Ireland and Bulgaria.

Ypsomed Delivery Systems

• With YDS SmartServices, Ypsomed offers its customers complete digital solutions.
• Based on the YpsoMate autoinjector, the Copaxone Pen is launched by Teva.

Ypsomed Group

• In Denmark, Finland and Norway, Ypsomed founds its subsidiaries.
• In Burgdorf, Switzerland, the new laboratory and the new tool manufacturing are put into operation.

Yposmed Diabetes Care

• The mylife YpsoPump insulin pump is launched in Sweden, Denmark, Austria, Finland, Poland, Belgium, Spain and Australia.
• They mylife OmniPod business is properly transferred to Insulet.
• The mylife Unio Neva blood glucose monitoring system with its automated data transfer to the mylife App is launched.
• The mylife App with integrated bolus calculator is available for download in the Apple App Store.

Ypsomed Delivery Systems

• With the PLAJEX syringe with Hulio by Terumo, an YpsoMate based autoinjector is commercially launched for the first time.

Ypsomed Group

• In Canada, Ypsomed founds its first North American subsidiary.
• In Belgium, Poland and Spain, Ypsomed founds its subsidiary.
• In Schwerin, Germany, Ypsomed starts with the construction of the new production site for injection and infusion systems.
• In Solothurn, Switzerland, Ypsomed commissions a new production line for various injection systems.

Ypsomed Diabetes Care

• The mylife YpsoPump insulin pump is launched in France, the Czech Republic, Switzerland and Italy.
• The mylife App with integrated blous calculator is available for download in the Google Play Store.

Ypsomed Delivery Systems

• Based on the UnoPen, the TYMLOS pen with abaloparatide is launched by Radius.
• Based on the UnoPen, the GLARIN insulin pen is launched by Koçak.
• Based on the YpsoPen, the insulin pen INSUPen Pro is launched by Biocon.

Ypsomed Group

• In Australia, Ypsomed founds its subsidiary.
• Ypsomed and Novo Nordisk agree on a cooperation for the mylife YpsoPump in combination with the NovoRapid PumpCart.

Ypsomed Diabetes Care

• The mylife YpsoPump insulin pump is launched in Germany, UK and the Netherlands.
• The mylife Software for simple therapy management is launched.

Ypsomed Delivery Systems

• Based on the ServoPen, the RinsaPen insulin pen is launchey by Geropharm.

Ypsomed Group

• In China, Ypsomed founds its subsidiary.

Ypsomed Diabetes Care

• The mylife Clickfine DiamondTip pen needle with 6 bevel tip is launched.
• The mylife Clickfine AutoProtect 5 mm / 31G needle is launched.

Ypsomed Delivery Systems

• Based on the YpsoPen, the Lupisulin insulin pen is launched by Lupin.
• Based on the YpsoPen, the PolhuminPen insulin pen is launched by Polfa Tarchomin.
• Based on the YpsoPen, the id Pen for insulin is launched by Indar.
• With the BiomatikPen 2 insulin pen by Pharmastandard, an UnoPen based product is launched for the first time.

Ypsomed Group

• Simon Michel takes over the position of CEO from Willy Michel.

Ypsomed Delivery Systems

• The Albiglutide LyoTwist is launched by GlaxoSmithKline.
• With the Bydureon Pen for GLP-1 by AstraZeneca, a product based on the LyoTwist platform is launched for the first time.

Ypsomed Group

• In Italy, Ypsomed founds its subsidiary.

Ypsomed Diabetes Care

• The mylife Clickfine 4 mm / 32G needle is launched.
• The mylife Penfine Classic needle with the twist is launched.
• Ypsomed wins the Red Dot Design Award for mylife Unio.
• The mylife Unio blood glucose monitoring system and the mylife AutoLance are launched.
• The mylife Orbit Reservoir is launched.

Ypsomed Delivery Systems

• First clinical trials are carried out for the YpsoMate autoinjector.
• Based on the ServoPen, the Lupisulin Pen insulin pen is launched by Lupin.
• Based on the YpsoPen, the Sulin insulin pen is launched by Dongbao.
• Based on the YpsoPen, the Biosulin insulin pen is launched by MJ Biopharm.

Ypsomed Group

• In Austria, Ypsomed founds its subsidiary.

Ypsomed Diabetes Care

• The mylife DailyDose self-injection system is launched.
• The second generation of the mylife OmniPod insulin patch pump is launched.

Ypsomed Delivery Systems

• Based on the ServoPen, the AnsuPen insulin pen is launched by Square.
• Based on the ServoPen, the ConviPen insulin pen is launched by Incepta.

Ypsomed Group

• Ypsomed acquires the infusion business Orbit from ICU Medical, USA.

Ypsomed Diabetes Care

• The Orbit infusion set for Luer-based insulin pumps is launched.
• The mylife SafetyLancets are launched.

Ypsomed Delivery Systems

• The umbrella brand Ypsomed Delivery Systems (YDS) is launched.
• Based on the ServoPen, the Omnifill insulin pen is launched by B. Braun.

Ypsomed Group

• In UK, Ypsomed founds its subsidiary.

Ypsomed Diabetes Care

• They mylife OmniPod insulin patch pump is launched.
• The second generation of the mylife "click-on" safety pen needles is launched.
• Ypsomed wins the Good Design Award for its Clickfine AutoProtect pen needles.

Ypsomed Delivery Systems

• With the Gansulin insulin pen by Dongbao, a ServoPen based product, is launched for the first time.
• The disposable pen Genotropin GoQuick with hGH is launched by Pfizer.
• The BiomatikPen insulin pen is launched by Pharmstandard.

Ypsomed Group

• Ypsomed buys 10 % of shares in Bionime Corp., Taiwan.

Ypsomed Diabetes Care

• The umbrella brand mylife Diabetescare is launched.
• The mylife Pura blood glucose monitoring system is launched.

Ypsomed Delivery Systems

• Ypsomed manufactures components for the SoloStar pen of Sanofi-Aventis.
• Ypsomed wins the Red Dot Design Award for its ServoPen platform.

Ypsomed Group

• In India, Ypsomed founds its subsidiary.
• In Burgdorf, Switzerland, Ypsomed opens the new Ypsomed logistics and manufacturing site.

Ypsomed Delivery Systems

• The disposable SymlinPen is launched by Amylin Pharmaceuticals.
• The YpsoPen Polfa insulin pen is launched by Polfa Tarchomin.

Ypsomed Group

• In Germany, Ypsomed acquires various diabetes sales organisations.

Ypsomed Delivery Systems

• The reusable HumatroPen 3 with hGH is launched by Eli Lilly.

Ypsomed Group

• In Solothurn, Switzerland, Ypsomed acquires a new production site.
• In Japan, Ypsomed is certified as foreign manufacturer.

Ypsomed Delivery Systems

• The Preotact Pen for PTH is launched by Nycomed.
• The Dongbao electronic insulin pen is launched by Dongbao.

Ypsomed Group

• In the Czech Republic, Ypsomed founds its subsidiary.

Ypsomed Delivery Systems

• The world's first semi-disposable injection system for insulin, the OptiClik pen system, is launched by Sanofi-Aventis.

Ypsomed Group

• Ypsomed is listed on the Swiss Stock Exchange.

Ypsomed Delivery Systems

• The disposable Gonal-f Pen for FSH is launched by Merck-Serono.